| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680526 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 10 Pages |
Abstract
The strong effect of cDMARD use on halving of dementia risk requires replication in a trial and may provide an important therapeutic pharmacological treatment.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Andy Judge, Cesar Garriga, Nigel K. Arden, Simon Lovestone, Dani Prieto-Alhambra, Cyrus Cooper, Christopher J. Edwards,